Glaucoma Device Maker Glaukos Sets Terms For $80M IPO
Venture capital-backed glaucoma treatment maker Glaukos Corp. set terms for its initial public offering on Monday, looking to raise as much as $80.4 million to further develop its medical devices and...To view the full article, register now.
Already a subscriber? Click here to view full article